Medical news
of the North Caucasus
Scientific journal
Mass media registration certificate dated December 7, 2006.
Series ПИ #ФС 77-26521.
Federal service for surveillance over non-violation of the legislation in the sphere of mass communications and protection of cultural heritage.
ISSN 2073-8137

Site search

Correspondence address
310 Mira Street, Stavropol, Russia, 355017

+7 8652 352524; +7 8652 353229.

+7 8652 352524.


The first russian consensus on the quantitative assessment of the adherence to treatment

Nikolai Nikolaev; Anatolii Martynov; Yulia Skirdenko; Oksana Drapkina; Mariya Livzan; C. Moiseev; Svetlana Bunova; Inna Viktorova; Vladimir S. Zadionchenko; Leonid B. Lazebnik;

The first Russian Consensus on the quantitative assessment of the adherence to treatment approved by the XII National Congress of physicians (Moscow, 22–24 November 2017). The Consensus on the quantitative evaluation of the adherence to treatment in clinical practice and working out the most effective strategies of therapy for the patients needing a long-term or permanent treatment has been developed for the first time. In medical practice, where questionnaires are preferable, allowing to investigate the adherence quantitatively and which are applied commonly for patients with different diseases, have the ability of automated input and data processing. Consequently, the Russian questionnaire of the quantitative assessment of the adherence to treatment QAA-25. The identified adherence is used to forecast the effectiveness of specific interventions. For this purpose, the obtained data of the respondent’s adherence are compared to the ranges of values corresponding to the appropriate levels of adherence (high, medium, or low). If the value of the identified adherence indicator falls within the values range of the corresponding level, this indicates the forecast variant of the intervention effectiveness, which is the most likely for all values within such a scale. This does not exclude that in some cases the individual characteristics of a particular respondent or other unforeseen external influences may affect the actual effectiveness of interventions due to that they may be more or less effective than it is forecast.


1. Drapkina O. M., Livzan M. A., Martynov A. I. [et al.] The first Russian consensus on quantitative
assessment of treatment adherence: basic principles, algorithms and recommendations. Medicinskii vestnik Severnogo Kavkaza. – Medical News of North Caucasus. 2018;13;1.2;259-273.
2. Nikolaev N. A., Skirdenko Yu. P. Russian generic questionnaire for evaluation of compliance to drug herapy. Klinicheskaja farmakologija i terapija. 2018;1(27):74-78.
3. Nikolaev N. A. Demonstrative hypertesoilogy: individualized hypotensive therapy. M.: Izdatel’skij dom Akademii Estestvoznanija, 2015.
4. Nikolaev N. A., Skirdenko Yu. P., Zherebilov V. V. Quantitative assessment of adherence to treatment in clinical medicine:protocol, procedure, interpretation. Kachestv. klinich. praktika. 2016;1:50-59.
5. Nikolaev N. A. Guide to clinical trials of internal diseases. M.: Izdatel’skij dom Akademii Estestvoznanija; 2015.
6. Chukaeva I. I. What is Compliance and What Can We Do to Improve It? Lechebnoe delo. 2012;2:21-26.
7. Atkinson M. J., Sinha A., Hass S. L. [et al.] Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual. Life Outcomes. 2004;2:12.
8. Benner J. S., Tierce J. C., Ballantyne C. M. [et al.] Follow-up lipid tests and physician visits are associated with improved adherence to statin therapy. Pharmacoeconomics. 2004;22(3):13-23.
9. Brown M. J. Resistant hypertension: resistance to treatment or resistance to taking treatment? Heart. 2014;100(11):821-822.
10. Burnier M. Managing ‘resistance’: is adherence a target for treatment? Curr. Opin. Nephrol. Hypertens. 2014;23(5):439-443.
11. DiMatteo M. R., Giodani P. J., Lepper Y. S., Croghan T. W. Patient adherence and medical treatment outcome: a meta-analysis. Med. Care. 2002;40(9):794-811.
12. Garcia A., Leiva F., Martos F., Garcia A. [et al.] How to diagnose adherence to treatment in primary health care? Medicina de Familia. 2000;1:13-19.
13. Haynes R. B., McDonald H., Garg A. X., Montague P. Interventions for helping patients to follow prescriptions for medications.Cochrane Database Syst. Rev. 2002: CD000011.
14. Horne R., Weinman J., Barber N. [et al.] Concordance, adherence and compliane in medicine taking. Report for the National Co-ordinating Centre for NHS Service Delivery and Organisation R & D. 2005.
15. Intas G., Kalogianni A., Stergiannis P., Bratakos M. [et al.] Development and validation of a diabetes self-care activities questionnaire. Journal of Diabetes Nursing.2012;3(16):100-110.
16. Morisky D. E., Green L. W., Levine D. M. Concurrent and predictive validity of a self-reported measure of medication adherence. Med. Care. 1986;24:67-74.
17. Morisky D. E., Ang A., Krousel-Wood M., Ward H. J. Predictive validity of a medication adherence easure in an outpatient setting. J. Clin. Hypertens (Greenwich). 2008;10(5):348-354.
18. Munger M. A., Van Tassell B. W., LaFleur J. Medication nonadherence: an unrecognized cardiovascular risk factor. Med. Gen. Med. 2007;9(3):58.
19. Osterberg L., Blaschke T. Adherence to medication. N. Engl. J. Med. 2005;353(5):487-497.
20. Pérez-Escamilla B., Franco-Trigo L., Moullin J. C. [et al.] Identification of validated questionnaires to measure adherence to pharmacological antihypertensive treatments. Patient Prefer Adherence. 2015;9:569-578.
21. Skovlund S. E. Patient-reported Assessments in Diabetes Care: Clinical and Research Applications. Current Diabetes Reports. 2005;5:115-123.
22. The ISPOR Compliance and Persistence SIG Definitions Working Group. Available at: www.ispor.org/sigs/medication. asp. Accessed March 2018.
23. Wilke T., Müller S. Nonadherence in Outpatient Thromboprophylaxis after Major Orthopedic Surgery: A Systematic Review. Expert. Rev. Pharmacoeconomics Outcomes Res.2010;10(6):691-700.
24. World Health Organization: Adherence to long-term therapies: evidence for action. 2003. Available at: www.who.int/chp/knowledge/publications/adherence_full_report.pdf. Accessed March 27, 2018.
25. World Health Organization. Secondary prevention of non-communicable disease in low and middle-income countries through community-based and health service interventions. 2002. Available at:http://apps.who.int/iris/bitstream/handle/10665/42567/WHO_MPN_CVD_2002.01.pdf?sequence=1&isAllowed=y. Accessed March 27, 2018.

Keywords: adherence to treatment, quantitative assessment, recommendations, Russian consensus

Stavropol State Medical Academy
Pyatigorsk State Research Institute of Balneotherapeutics
Pyatigorsk State Pharmaceutical Academy